EP1149128A1 - Rubber balloon for ambulatory infusion - Google Patents

Rubber balloon for ambulatory infusion

Info

Publication number
EP1149128A1
EP1149128A1 EP00970667A EP00970667A EP1149128A1 EP 1149128 A1 EP1149128 A1 EP 1149128A1 EP 00970667 A EP00970667 A EP 00970667A EP 00970667 A EP00970667 A EP 00970667A EP 1149128 A1 EP1149128 A1 EP 1149128A1
Authority
EP
European Patent Office
Prior art keywords
butyl
rubber
balloon
antioxidant
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00970667A
Other languages
German (de)
French (fr)
Inventor
Angeles Lillian Buan
Tu Le
Yuan-Pang Samuel Ding
Dennis Jenke
Mihir Sheth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter International Inc filed Critical Baxter International Inc
Publication of EP1149128A1 publication Critical patent/EP1149128A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/14—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/148—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags
    • A61M5/152—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons flexible, e.g. independent bags pressurised by contraction of elastic reservoirs
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/34—Silicon-containing compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/13—Phenols; Phenolates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L9/00—Compositions of homopolymers or copolymers of conjugated diene hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Definitions

  • the present invention relates generally to an infusor balloon and more specifically to a burst resistant rubber balloon for infusion of a therapeutic agent in a liquid form.
  • Medical infusors often include a balloon for containing a dosage amount of a therapeutic agent and for supplying the therapeutic agent under pressure to the vascular system of a patient. It is critical that the balloon resist any material failure such as cracking or bursting that will compromise the delivery of the dosage amount.
  • U.S. Patent Nos. 4,201,207, and 4,938,751 discloses an infusor bladder of a vulcanized synthetic polyisoprene having 90-98% cis linkages that has been vulcanized with an organic peroxide such as dicumyl peroxide at a concentration of 5.5 x 10 "3 to 7.5 x 10' 3 moles of peroxide per 100 grams of polyisoprene.
  • the '751 Patent discloses a method for preparing an infusor bladder.
  • the process includes the steps of blending polyisoprene having 90-98% of its monomeric units joined in cis- 1,4 orientation, with carbon black or silicon dioxide or a mixture of the two.
  • a blend of these components are vulcanized by adding a vulcanizing agent such as dicumyl peroxide and subjecting the blend to vulcanization conditions. (Col.2, line 63-col. 3, line 6).
  • the step of vulcanizing is taken during the step of forming the mixture into tubular bodies (col. 3, lines 7-21). After the mixture is formed into a tubular body, the body is extracted with a solvent to remove the unreacted vulcanizing agents and the degradation products of the vulcanizing agent (col. 3, lines 22-25).
  • an antioxidant is imbibed into the bodies by placing them in contact with a solution of the antioxidant (col. 3, lines 34-36). After the imbibing step the bodies are dried to remove the solvent from the imbibing step (col. 4, lines 2-4).
  • This process has at least the following areas for improvement.
  • First, the imbibing process is a time consuming and expensive process.
  • the present invention provides a composition for a medical infusor balloon.
  • the composition includes: (1) a polyisoprene rubber, (2) an organic peroxide catalyst from 0.5-3.0 parts per hundred parts by weight of the rubber, (3) a filler and (4) an antioxidant from 0.6-3.0 parts per hundred parts by weight of the rubber.
  • the rubber is polyisoprene
  • the catalyst is dicumyl peroxide
  • the antioxidant is l,3,5-trimethyl-2,4,6-tris(3,5- di-t-butyl-4-hydroxybenzyl)-benzene or octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propio- nate.
  • the infusor balloon of the present invention should have an increased resistance to burst over prior infusor balloons.
  • the present invention also provides a method for fabricating a medical infusor balloon. The method comprises the steps of: (1) providing a polyisoprene rubber, (2) providing an organic peroxide catalyst in an amount from about 0.5 to about 3.0 parts per one hundred parts rubber, (3) providing a filler, (4) providing an antioxidant selected from the group consisting of hindered phenols and hindered polyphenols and in an amount from about 0.6 to about 3.0 parts per one hundred parts of rubber, (5) mixing the rubber, the catalyst, the filler and the antioxidant to define a blend; (6) vulcanizing the blend and (7) extruding the blend into a balloon having an average resistance to burst for 40 balloons filled with water of greater than 3 days when stored at 90 °C at greater than 80% relative humidity for a balloon in the uninflated state having a length of about 3 inches, a wall thickness of about 0.038 inches, an inner
  • Figure 1 shows a infusor balloon of the present invention.
  • Figure 1 shows a medical infusor balloon 10 of the present invention.
  • the balloon has a monolayer sidewall 12 defining an internal reservoir 14 for containing a dosage amount of a therapeutic agent such as a drug for delivery under pressure to the vascular system of a patient.
  • the reservoir 14 in the uninflated state has a wall thickness from about 0.033 inches to about 0.043 inches, an inner diameter of from about 0.151 to about 0.165 inches and when inflated with about 60 mL of water, the water is under pressure from about 9.0-11.0 psi and more preferably from about 9.5 psi to about 10.0 psi.
  • the balloon is fabricated from a blend of a rubber, a filler, a catalyst and an antioxidant.
  • the present composition includes the antioxidant together with an organic peroxide catalyst in the blend prior to vulcanizing or curing the blend and processing the blend into a balloon.
  • the blend has about 100 parts of the rubber, from about 0.5-3.0 parts and more preferably from about 1.0-2.0 parts of the catalyst, from about 0.6-3.0 parts of the antioxidant, and from about 3-10 parts of the filler.
  • the rubber should be selected from any suitable polyisoprene rubber that provides adequate strength after processing to form a medical infusor balloon.
  • the rubber is polyisoprene sold by Goodyear Tire and Rubber Company under the product designation NATSYN 2205.
  • the catalyst should be an organic peroxide and in a preferred form of the invention is a dicumyl peroxide. In a preferred form of the invention the catalyst is sold by Hercules Chemical Company under the trade name Di Cup-R.
  • the antioxidant should be an additive that is capable of minimizing the degradation of the blend components during processing and preferably is a hindered phenol or a hindered polyphenol.
  • Suitable antioxidants include, but are not limited to, tetrakis [methylene 3-(3',5'-di- t-butyl-4'-hydroxyphenyl) propionate] methane, l,3,5-trimethyl-2,4,6-tris(3,5-di-t-butyl-4- hydroxybenzyl)-benzene, 2,6-di-t-butyl-4-methylphenol and octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate.
  • the antioxidant is 1,3,5- trimethyl-2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene sold by Albemarle under the product designation ETHANOX 330 or an octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate sold by Seiba-Geigy under the trade name IRGANOX 1076.
  • the filler preferably adds strength to the blend and preferably is selected from the group consisting of fumed silicon dioxides. In a preferred form of the invention the filler is sold by DeGusse under the product designation AEROSIL 200.
  • the balloon will have the following physical properties: (1) a 100% modulus of preferably less than about 300 psi, more preferably less than about 250 psi, and most preferably less than 200 psi; (2) an average stress at break of greater than about 500 psi (3); a percent strain at break of preferably greater than about 400%, more preferably greater than about 450% and most preferably greater than about 500%; (4) an antioxidant content of from 0.7-1.0% by weight of the composition, and (5) has an average resistance to burst for 40 balloons filled with water of greater than 3 days when stored at 90 °C at greater than 80% relative humidity for a balloon in the uninflated state having a length of about 3 inches, a wall thickness of about 0.038 inches, an inner diameter of about 0.158 inches and the balloon is cured to the extent that when filled with 60 mL of water the water has a pressure of about 10 psi.
  • the method for fabricating the blend into an infusor balloon requires the following steps. First, the blend components are blended in a high intensity blender such as a Banbury mixer, a twin screw mixer or a continuous high intensity mixer. After the components are adequately blended the blend is optionally milled in a two-roll mill. The blended components are then cut into strips. These strips are put into a first extruder with a fine screen pack to remove particulate matter that may cause bursting of the balloon. After the screening step, the screened strips are placed in a second extruder and are extruded into tubes. The tubes exiting the extruder are passed through a salt bath of sodium nitrate and potassium nitrate to cure the tubes and the tubes are cut to size. After the salt curing step the tube segments are placed in an oven to volatilize the unwanted residues.
  • a high intensity blender such as a Banbury mixer, a twin screw mixer or a continuous high intensity mixer.
  • the blended components are then cut into strips. These strips are put into a first ex
  • the first group of samples denoted as Control were fabricated from a composition that did not include an antioxidant during the steps of processing the composition into tubes. An antioxidant was added in a separate imbibing step after processing. This process is consistent with the disclosure of U.S. Patent No. 4,938,751.
  • the following components were blended in a Banbury mixer: 100 parts NATSYN 2205 (polyisoprene), 5 parts AEROSIL 200 (filler), 1.5 parts Di-Cup R (catalyst).
  • the blend was milled in a 2-roll mill. The milled blend was extruded through a screen pack to eliminate particulate matter.
  • the screened composition was then extruded into tubes and cured in a salt bath of sodium nitrate and potassium nitrate.
  • the tubes were cut into 3 inch lengths and filled with 60 mL of water and were found to have a water pressure of about 10 psi.
  • the tubes were then subjected to an imbibing process where the tubes were submerged in Ethanox 330 dissolved in ethyl acetate. The tubes were allowed to reside in this solution for a 24 hour period. The tubes were allowed to dry by evaporation of the solvent.
  • the second group of balloons denoted as Example, were fabricated in a process subject of the present invention where the antioxidant was added during the initial blending step.
  • the process included the steps of blending in a Banbury mixer 100 parts Natsyn 2205 (polyisoprene), 5 parts Aerosil 200 (filler), 1.73 parts Di-Cup R (catalyst), and 0.969 parts Ethanox 330 (antioxidant) and milling the components in a 2-roll mill.
  • the milled blend was extruded through a screen pack to eliminate particulate matter.
  • the screened composition was then extruded into tubes and cured in a salt bath of sodium nitrate and potassium nitrate.
  • the tubes were cut into 3 inch lengths and filled with about 60 mL of water and were found to have a water pressure of about 10 psi.
  • the tubes were then placed in an oven at 180° C for 14 hours to volatilize unwanted residues.
  • the balloons from the Control and the Example were compared for burst strength.
  • the burst strength test was conducted using the following procedure: (1) fill the balloons with 60 mL deionized water, (2) hang the filled reservoirs vertically inside a plastic container, (3) fill the plastic container with water to a point below the reservoirs, (4) cap the container as tight as possible to maintain high humidity inside the container, (5) place the container with reservoirs in a air circulating oven set at 90 °C, and (6) record the time it takes for the reservoirs to burst.
  • Example 2 Infusor balloon were fabricated from a formulation having 100 parts polyisoprene, 5 parts filler, 1.5 parts catalyst and 0.5 parts antioxidant. The formulation components were mixed in a high intensity mixer, then milled in a two-roll mill, the milled formulation was then cut into strips. The strips were extruded with a fine screen pack and then extruded a second time into tubes. The tubes were passed through a salt bath of sodium nitrate and potassium nitrate to cure the rubber. The cured tubes were placed in an oven to volatilize unwanted residues. The resulting infusor balloons readily stuck to one another and to themselves. These infusor balloons are unsuitable for use in the infusor device shown in Figure 1 as they would adhere to the sidewalls of the device which in turn would lead to an unacceptably high burst rate.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)

Abstract

The present invention provides a composition for a medical infusor balloon. The composition includes: (1) a polyisoprene rubber, (2) an organic peroxide catalyst from 0.5-3.0 parts per hundred parts by weight of the rubber, (3) a filler and (4) an antioxidant from 0.6-3.0 parts per hundred parts by weight of the rubber.

Description

RUBBER B LLOON FOR AMBULATORY INFUSION DESCRIPTION
Technical Field
The present invention relates generally to an infusor balloon and more specifically to a burst resistant rubber balloon for infusion of a therapeutic agent in a liquid form.
Background Prior Art
In the medical field therapeutic agents are often administered over time using medical infusor devices. Medical infusors often include a balloon for containing a dosage amount of a therapeutic agent and for supplying the therapeutic agent under pressure to the vascular system of a patient. It is critical that the balloon resist any material failure such as cracking or bursting that will compromise the delivery of the dosage amount.
A prior attempt at providing a balloon for an infusor devices is disclosed in U.S. Patent Nos. 4,201,207, and 4,938,751. The '207 Patent discloses an infusor bladder of a vulcanized synthetic polyisoprene having 90-98% cis linkages that has been vulcanized with an organic peroxide such as dicumyl peroxide at a concentration of 5.5 x 10"3 to 7.5 x 10'3 moles of peroxide per 100 grams of polyisoprene. The '751 Patent discloses a method for preparing an infusor bladder. The process includes the steps of blending polyisoprene having 90-98% of its monomeric units joined in cis- 1,4 orientation, with carbon black or silicon dioxide or a mixture of the two. A blend of these components are vulcanized by adding a vulcanizing agent such as dicumyl peroxide and subjecting the blend to vulcanization conditions. (Col.2, line 63-col. 3, line 6). The step of vulcanizing is taken during the step of forming the mixture into tubular bodies (col. 3, lines 7-21). After the mixture is formed into a tubular body, the body is extracted with a solvent to remove the unreacted vulcanizing agents and the degradation products of the vulcanizing agent (col. 3, lines 22-25). After the extraction process an antioxidant is imbibed into the bodies by placing them in contact with a solution of the antioxidant (col. 3, lines 34-36). After the imbibing step the bodies are dried to remove the solvent from the imbibing step (col. 4, lines 2-4). This process has at least the following areas for improvement. First, the imbibing process is a time consuming and expensive process. Second, during the manufacturing process, all of the steps taken prior to the imbibing steps subject the bodies to high heat and shear without the presence of a sufficient amount of antioxidant to protect the components from oxidative and thermal degradation. While there is a trace amount of antioxidant present in the rubber when purchased it is not sufficient to provide a significant amount of protection. It was commonly believed when using a peroxide catalyst that an antioxidant should not be incorporated into the component blends prior to vulcanization as the antioxidant would react with the peroxide so that the peroxide would not be available for the curing of the rubber.
Summary of the Invention
The present invention provides a composition for a medical infusor balloon. The composition includes: (1) a polyisoprene rubber, (2) an organic peroxide catalyst from 0.5-3.0 parts per hundred parts by weight of the rubber, (3) a filler and (4) an antioxidant from 0.6-3.0 parts per hundred parts by weight of the rubber. In a preferred form of the invention the rubber is polyisoprene, the catalyst is dicumyl peroxide, the antioxidant is l,3,5-trimethyl-2,4,6-tris(3,5- di-t-butyl-4-hydroxybenzyl)-benzene or octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propio- nate. Also the infusor balloon of the present invention should have an increased resistance to burst over prior infusor balloons. The present invention also provides a method for fabricating a medical infusor balloon. The method comprises the steps of: (1) providing a polyisoprene rubber, (2) providing an organic peroxide catalyst in an amount from about 0.5 to about 3.0 parts per one hundred parts rubber, (3) providing a filler, (4) providing an antioxidant selected from the group consisting of hindered phenols and hindered polyphenols and in an amount from about 0.6 to about 3.0 parts per one hundred parts of rubber, (5) mixing the rubber, the catalyst, the filler and the antioxidant to define a blend; (6) vulcanizing the blend and (7) extruding the blend into a balloon having an average resistance to burst for 40 balloons filled with water of greater than 3 days when stored at 90 °C at greater than 80% relative humidity for a balloon in the uninflated state having a length of about 3 inches, a wall thickness of about 0.038 inches, an inner diameter of about 0.158 inches and the balloon is cured to the extent that when filled with 60 mL of water the water has a pressure of about 10 psi. The present invention also provides a medical infusor balloon fabricated from the formulation set forth above and by the method set forth above.
Brief Description of the Drawings Figure 1 shows a infusor balloon of the present invention.
Detailed Description
While this invention is susceptible of embodiments in many different forms, and will herein be described in detail, preferred embodiments of the invention are disclosed with the under- standing that the present disclosure is to be considered as exemplifications of the principles of the invention and are not intended to limit the broad aspects of the invention to the embodiments illustrated.
Figure 1 shows a medical infusor balloon 10 of the present invention. The balloon has a monolayer sidewall 12 defining an internal reservoir 14 for containing a dosage amount of a therapeutic agent such as a drug for delivery under pressure to the vascular system of a patient. In a preferred form of the invention, the reservoir 14 in the uninflated state has a wall thickness from about 0.033 inches to about 0.043 inches, an inner diameter of from about 0.151 to about 0.165 inches and when inflated with about 60 mL of water, the water is under pressure from about 9.0-11.0 psi and more preferably from about 9.5 psi to about 10.0 psi. The balloon is fabricated from a blend of a rubber, a filler, a catalyst and an antioxidant. Unlike the prior art compositions for infusor balloons, the present composition includes the antioxidant together with an organic peroxide catalyst in the blend prior to vulcanizing or curing the blend and processing the blend into a balloon. In a preferred form of the invention, the blend has about 100 parts of the rubber, from about 0.5-3.0 parts and more preferably from about 1.0-2.0 parts of the catalyst, from about 0.6-3.0 parts of the antioxidant, and from about 3-10 parts of the filler. The rubber should be selected from any suitable polyisoprene rubber that provides adequate strength after processing to form a medical infusor balloon. In a preferred form of the invention the rubber is polyisoprene sold by Goodyear Tire and Rubber Company under the product designation NATSYN 2205. The catalyst should be an organic peroxide and in a preferred form of the invention is a dicumyl peroxide. In a preferred form of the invention the catalyst is sold by Hercules Chemical Company under the trade name Di Cup-R. The antioxidant should be an additive that is capable of minimizing the degradation of the blend components during processing and preferably is a hindered phenol or a hindered polyphenol. Suitable antioxidants include, but are not limited to, tetrakis [methylene 3-(3',5'-di- t-butyl-4'-hydroxyphenyl) propionate] methane, l,3,5-trimethyl-2,4,6-tris(3,5-di-t-butyl-4- hydroxybenzyl)-benzene, 2,6-di-t-butyl-4-methylphenol and octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate. In the most preferred form of the invention the antioxidant is 1,3,5- trimethyl-2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene sold by Albemarle under the product designation ETHANOX 330 or an octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate sold by Seiba-Geigy under the trade name IRGANOX 1076. The filler preferably adds strength to the blend and preferably is selected from the group consisting of fumed silicon dioxides. In a preferred form of the invention the filler is sold by DeGusse under the product designation AEROSIL 200.
In a preferred form of the invention the balloon will have the following physical properties: (1) a 100% modulus of preferably less than about 300 psi, more preferably less than about 250 psi, and most preferably less than 200 psi; (2) an average stress at break of greater than about 500 psi (3); a percent strain at break of preferably greater than about 400%, more preferably greater than about 450% and most preferably greater than about 500%; (4) an antioxidant content of from 0.7-1.0% by weight of the composition, and (5) has an average resistance to burst for 40 balloons filled with water of greater than 3 days when stored at 90 °C at greater than 80% relative humidity for a balloon in the uninflated state having a length of about 3 inches, a wall thickness of about 0.038 inches, an inner diameter of about 0.158 inches and the balloon is cured to the extent that when filled with 60 mL of water the water has a pressure of about 10 psi.
The method for fabricating the blend into an infusor balloon requires the following steps. First, the blend components are blended in a high intensity blender such as a Banbury mixer, a twin screw mixer or a continuous high intensity mixer. After the components are adequately blended the blend is optionally milled in a two-roll mill. The blended components are then cut into strips. These strips are put into a first extruder with a fine screen pack to remove particulate matter that may cause bursting of the balloon. After the screening step, the screened strips are placed in a second extruder and are extruded into tubes. The tubes exiting the extruder are passed through a salt bath of sodium nitrate and potassium nitrate to cure the tubes and the tubes are cut to size. After the salt curing step the tube segments are placed in an oven to volatilize the unwanted residues. The following are non-limiting examples of the invention and should not be used to limit the scope of the claims set forth below. Example 1
Two groups of infusor balloons were fabricated. The first group of samples denoted as Control were fabricated from a composition that did not include an antioxidant during the steps of processing the composition into tubes. An antioxidant was added in a separate imbibing step after processing. This process is consistent with the disclosure of U.S. Patent No. 4,938,751. In particular the following components were blended in a Banbury mixer: 100 parts NATSYN 2205 (polyisoprene), 5 parts AEROSIL 200 (filler), 1.5 parts Di-Cup R (catalyst). The blend was milled in a 2-roll mill. The milled blend was extruded through a screen pack to eliminate particulate matter. The screened composition was then extruded into tubes and cured in a salt bath of sodium nitrate and potassium nitrate. The tubes were cut into 3 inch lengths and filled with 60 mL of water and were found to have a water pressure of about 10 psi. The tubes were then subjected to an imbibing process where the tubes were submerged in Ethanox 330 dissolved in ethyl acetate. The tubes were allowed to reside in this solution for a 24 hour period. The tubes were allowed to dry by evaporation of the solvent.
The second group of balloons, denoted as Example, were fabricated in a process subject of the present invention where the antioxidant was added during the initial blending step. The process included the steps of blending in a Banbury mixer 100 parts Natsyn 2205 (polyisoprene), 5 parts Aerosil 200 (filler), 1.73 parts Di-Cup R (catalyst), and 0.969 parts Ethanox 330 (antioxidant) and milling the components in a 2-roll mill. The milled blend was extruded through a screen pack to eliminate particulate matter. The screened composition was then extruded into tubes and cured in a salt bath of sodium nitrate and potassium nitrate. The tubes were cut into 3 inch lengths and filled with about 60 mL of water and were found to have a water pressure of about 10 psi. The tubes were then placed in an oven at 180° C for 14 hours to volatilize unwanted residues.
The balloons from the Control and the Example were compared for burst strength. The burst strength test was conducted using the following procedure: (1) fill the balloons with 60 mL deionized water, (2) hang the filled reservoirs vertically inside a plastic container, (3) fill the plastic container with water to a point below the reservoirs, (4) cap the container as tight as possible to maintain high humidity inside the container, (5) place the container with reservoirs in a air circulating oven set at 90 °C, and (6) record the time it takes for the reservoirs to burst. These data points are set forth below in Table 1.
Table- 1 Burst Time of Filled Reservoir at 90 Degree C
These data show that the average burst resistance for the Example balloons where the antioxidant is added prior to blending is greater than 4 days while the burst strength of the balloon made by the process where the antioxidant is added after processing is less than 3 days.
Example 2: Infusor balloon were fabricated from a formulation having 100 parts polyisoprene, 5 parts filler, 1.5 parts catalyst and 0.5 parts antioxidant. The formulation components were mixed in a high intensity mixer, then milled in a two-roll mill, the milled formulation was then cut into strips. The strips were extruded with a fine screen pack and then extruded a second time into tubes. The tubes were passed through a salt bath of sodium nitrate and potassium nitrate to cure the rubber. The cured tubes were placed in an oven to volatilize unwanted residues. The resulting infusor balloons readily stuck to one another and to themselves. These infusor balloons are unsuitable for use in the infusor device shown in Figure 1 as they would adhere to the sidewalls of the device which in turn would lead to an unacceptably high burst rate.
It will be understood that the invention may be embodied in other specific forms without departing from the spirit or central characteristics thereof. The present examples and embodiments, therefore, are to be considered in all respects as illustrative and not restrictive, and the invention is not to be limited to the details given herein.

Claims

CLAIMSWe claim:
1. A composition for a medical infusor balloon prior to vulcanization comprising: a polyisoprene rubber; an organic peroxide catalyst from 0.5-3.0 parts per hundred parts by weight of the rubber; a filler; and an antioxidant from 0.6-3.0 parts per hundred parts by weight of the rubber.
2. The composition of claim 1 wherein the filler is present in an amount from about 3-10 parts per hundred by weight of the rubber.
3. The composition of claim 2 wherein the filler is a fumed silicon dioxide.
4. The composition of claim 3 wherein the catalyst is dicumyl peroxide.
5. The composition of claim 4 wherein the antioxidant is selected from the group consisting of hindered phenols and hindered polyphenols.
6. The composition of claim 5 wherein the antioxidant is selected from the group consisting of tetrakis [methylene 3-(3',5'-di-t-butyl-4'-hydroxyphenyl) propionate] methane, 1,3,5-trimethyl- 2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene, 2,6-di-t-butyl-4-methylphenol and octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate.
7. The composition of claim 6 wherein the rubber is polyisoprene, the catalyst is dicumyl peroxide, the antioxidant is l,3,5-trimethyl-2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene or octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate, and the filler is fumed silicon dioxide.
8. A composition for a medical infusor balloon comprising: a polyisoprene rubber; an organic peroxide catalyst from 0.5-3.0 parts per hundred parts by weight of the rubber; a filler; an antioxidant from 0.6-3.0 parts per hundred parts by weight of the rubber; and wherein the antioxidant is added to the composition prior to vulcanization and an infusor balloon fabricated from this composition has an average resistance to burst for 40 balloons filled with water of greater than 3 days when stored at 90 °C at greater than 80% relative humidity for a balloon in the uninflated state having a length of about 3 inches, a wall thickness of about 0.038 inches, an inner diameter of about 0.158 inches and the balloon is cured to the extent that when filled with 60 mL of water the water has a pressure of about 10 psi.
9. The composition of claim 8 wherein the filler resin is present in an amount from about 3 to about 10 parts per hundred by weight of the rubber.
10. The composition of claim 9 wherein the catalyst is dicumyl peroxide.
11. The composition of claim 10 wherein the antioxidant is selected from the group consisting of hindered phenols and hindered polyphenols.
12. The composition of claim 11 wherein the antioxidant is selected from the group consisting of tetrakis [methylene 3-(3',5'-di-t-butyl-4'-hydroxyphenyl) propionate] methane, 1,3,5-trimethyl-
2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene, 2,6-di-t-butyl-4-methylphenol and octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate.
13. The composition of claim 12 wherein the filler is filmed silicon dioxide.
14. The composition of claim 13 wherein the rubber is polyisoprene, the catalyst is dicumyl peroxide, the antioxidant is l,3,5-trimethyl-2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene or octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate., and the filler is fumed silicon dioxide.
15. A method for fabricating a medical infusor balloon comprising the steps of: providing a polyisoprene rubber; providing an organic peroxide catalyst in an amount from about 0.5 to about 3.0 parts per one hundred parts rubber; providing a filler; providing an antioxidant selected from the group consisting of hindered phenols and hindered polyphenols and in an amount from about 0.6 to about 3.0 parts per one hundred parts of rubber; mixing the rubber, the catalyst, the filler and the antioxidant to define a blend; vulcanizing the blend; and extruding the blend into a balloon having an average resistance to burst for 40 balloons filled with water of greater than 3 days when stored at 90 °C at greater than 80% relative humidity for a balloon in the uninflated state having a length of about 3 inches, a wall thickness of about 0.038 inches, an inner diameter of about 0.158 inches and the balloon is cured to the extent that when filled with 60 mL of water the water has a pressure of about 10 psi.
16. The method of claim 15 wherein the filler is a fumed silicon dioxide.
17. The method of claim 16 wherein the antioxidant is selected from the group comprising tetrakis [methylene 3-(3',5'-di-t-butyl-4'-hydroxyphenyl) propionate] methane, 1,3,5-trimethyl- 2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene, 2,6-di-t-butyl-4-methylphenol and octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate.
18. The method of claim 17 wherein the rubber is polyisoprene, the catalyst is dicumyl peroxide, the antioxidant is l,3,5-trimethyl-2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene or octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate.
19. A medical infusor balloon comprising: a sidewall defining an inner chamber and having a fluid outlet, the sidewall fabricated from a composition of a polyisoprene rubber, an organic peroxide catalyst from about 0.5 to about 3.0 parts per hundred parts by weight of the rubber, a filler from about 3 to about 10 parts per hundred parts of the rubber, an antioxidant from about 0.6 to about 3.0 parts per hundred parts by weight of the rubber; and wherein the antioxidant is added to the composition prior to vulcanization and the infusor balloon has an average resistance to burst for 40 balloons filled with water of greater than 3 days when stored at 90 °C at greater than 80% relative humidity for a balloon in the uninflated state having a length of about 3 inches, a wall thickness of about 0.038 inches, an inner diameter of about 0.158 inches and the balloon is cured to the extent that when filled with 60 mL of water the water has a pressure of about 10 psi.
20. The balloon of claim 19 wherein the filler is fumed silicon dioxide.
21. The balloon of claim 19 wherein the catalyst is an organic peroxide.
22. The balloon of claim 19 wherein the antioxidant is selected from the group consisting of hindered phenols and hindered polyphenols.
23. The balloon of claim 22 wherein the antioxidant is selected from the group consisting of tetrakis [methylene 3-(3',5'-di-t-butyl-4'-hydroxyphenyl) propionate] methane, 1,3,5-trimethyl- 2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene, 2,6-di-t-butyl-4-methylphenol and octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate.
24. The balloon of claim 19 wherein the rubber is polyisoprene, the catalyst is dicumyl peroxide, the antioxidant is l,3,5-trimethyl-2,4,6-tris(3,5-di-t-butyl-4-hydroxybenzyl)-benzene or octadecyl 3-(3,5-di-t-butyl-4 hydroxyphenyl) propionate, and the filler is fumed silicon dioxide.
EP00970667A 1999-11-05 2000-10-06 Rubber balloon for ambulatory infusion Withdrawn EP1149128A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43494799A 1999-11-05 1999-11-05
US434947 1999-11-05
PCT/US2000/027790 WO2001034692A1 (en) 1999-11-05 2000-10-06 Rubber balloon for ambulatory infusion

Publications (1)

Publication Number Publication Date
EP1149128A1 true EP1149128A1 (en) 2001-10-31

Family

ID=23726358

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00970667A Withdrawn EP1149128A1 (en) 1999-11-05 2000-10-06 Rubber balloon for ambulatory infusion

Country Status (7)

Country Link
EP (1) EP1149128A1 (en)
JP (1) JP2003514091A (en)
KR (1) KR20010101378A (en)
CN (1) CN1335868A (en)
AU (1) AU8001500A (en)
CA (1) CA2356956A1 (en)
WO (1) WO2001034692A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938751A (en) * 1981-02-23 1990-07-03 Alza Corporation Elastomeric bladders for medical infusers
US4684672A (en) * 1983-01-10 1987-08-04 Buchanan Robert L Novel rubber connectors and other rubber parts for use in human infusion sets and rubber

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0134692A1 *

Also Published As

Publication number Publication date
KR20010101378A (en) 2001-11-14
AU8001500A (en) 2001-06-06
CA2356956A1 (en) 2001-05-17
JP2003514091A (en) 2003-04-15
WO2001034692A1 (en) 2001-05-17
CN1335868A (en) 2002-02-13

Similar Documents

Publication Publication Date Title
DE69230024T2 (en) Balloon for blood vessel dilatation catheter
JP2007507308A (en) Low extractable thermoplastic syringe and tip cap
JPH09506789A (en) Medical instruments and methods of making them
JP2009144167A (en) Medical tubing produced from polybutadiene
CN112469457B (en) Prefilled syringe and method of manufacturing prefilled syringe
EP0556034A1 (en) A medical instrument
EP3831429A1 (en) Pre-filled syringe and pre-filled syringe production method
JPH05317411A (en) Medical equipment material
DE69718361T2 (en) Process for the production of controlled release devices
EP1106190B1 (en) Medical tubing
EP1149128A1 (en) Rubber balloon for ambulatory infusion
US4938751A (en) Elastomeric bladders for medical infusers
EP3290025B1 (en) Stable infusion dosage form of morphine
JP2019506407A (en) Process for producing stable ready-to-use infusion bags for oxidation-sensitive formulations
KR20220043192A (en) syringe
FR2752380A1 (en) METHOD FOR MANUFACTURING A CONTROLLED RELEASE DEVICE
JP2005124870A (en) Rubber stopper for pharmaceutical container and manufacturing method thereof
CA1213097A (en) Elastomeric bladders for medical infusers
JP2577762B2 (en) Rubber products for pharmaceuticals and medical instruments
JPH0576589A (en) Natural rubber product for medical use and production thereof
CN114983936A (en) Octreotide acetate injection with good stability as well as preparation method and application thereof
CN106730045B (en) A kind of drug coating composition and preparation method thereof
CN101209238B (en) Biological degradation type long-acting subcutaneous contraception implant containing gestodene and preparation thereof
JPH02305834A (en) Radiation-resistant polybutadiene composition
EP3660071A1 (en) Biodegradable polyester and use thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010608

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LE, TU

Inventor name: DING, YUAN-PANG, SAMUAL

Inventor name: BUAN, ANGELES, LILLIAN

Inventor name: JENKE, DENNIS

Inventor name: SHETH, MIHIR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20030820